BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright ©The Author(s) 2025.
World J Crit Care Med. Dec 9, 2025; 14(4): 107570
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.107570
Table 1 Prespecified eligibility criteria
Participants
Interventions
Comparison
Outcomes
Study types
Age > 18 years; acute stroke patients receiving intravenous thrombolyticsIntervention group: Telemedicine (audio and video) evaluation by neurology specialistControl group: In-person evaluation by neurology specialistPrimary outcome: Door-to-needle time. Secondary outcomes: sICH; mortality; mRS ≤ 2; only studies evaluating one or more of these outcomesRCT; observational cohort study
Table 2 Characteristics of included studies, mean ± SD/median (25th-75th percentiles)
Ref.
Country
Telemedicine
In-person
DTN, in minutes
sICH
Mortality
Favorable short-term outcome
Loggini et al[6], 2024United Statesn = 142n = 97TM: 55 (43-73); IP: 42 (35-54)TM: 3; IP: 3TM: 8; IP: 9TM: 98; IP: 60
Ho et al[23], 2024Canadan = 55n = 247TM: 35.5 ± 12.7; IP: 34 ± 15.9TM: 0; IP: 4TM: 7; IP: 40-
Riegler et al[25], 2023Germanyn = 50n = 42TM: 65 (43-78); IP: 37 (25-51)TM: 10; IP: 10TM: 15; IP: 8TM: 4; IP: 15
Lin et al[22], 2022Taiwann = 25n = 153TM: 62 (53-78); IP: 51 (41-65)TM: 1; IP: 5TM: 4; IP: 14TM: 15; IP: 91
Zhang et al[20], 2020Chinan = 235n = 588TM: 62 ± 12; IP: 47 ± 8---
Sobhani et al[27], 2021United Statesn = 55n = 77TM: 56.8; IP: 41.5--TM: 29/44; IP: 27/57
Asaithambi et al[24], 2017United Statesn = 52n = 65TM: 54 (41-72); IP: 43 (35-55)TM: 0; IP: 1TM: 2; IP: 1-
Nardetto et al[21], 2016Italyn = 25n = 106TM: 73 (98-121); IP: 95 (82-125)TM: 2; IP: 3-TM: 12; IP: -
Raulot et al[19], 2015Francen = 27n = 70TM: 86 (63-94); IP: 55 (45-64)TM: 1; IP: 5-TM: 8; IP: 22
Chowdhury et al[17], 2012United Kingdomn = 45n = 52TM: 61; IP: 33TM: 2; IP: 4-TM: 19
IP: 19
Zaidi et al[26], 2011United Statesn = 83n = 59TM: 89.9 ± 36.3; IP: 67.8 ± 26.1TM: 1; IP: 3TM: 18; IP: 26TM: 22; IP: 35